Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Huperzine for Cognitive and Functional Impairment in Schizophrenia

NCT00963846 is registered in ClinicalTrials.gov with Biomedisyn Corporation as lead sponsor.

NCT NCT00963846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00963846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Huperzine for Cognitive and Functional Impairment in Schizophrenia
Lead sponsor
Biomedisyn Corporation
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
December 31, 2012
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia